To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene TADA2BTABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
166 supporting clones for gene TADA2B back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DB501524 hypothalamus TADA2B.a 1 to 471 1 to 472   tiling clone,   472/472
(100 %)
2 diff
(99.6 %id)
BU860474 adenocarcinoma, cell line, breast TADA2B.a 66 to 903 1 to 843   tiling clone,   843/844
(99 %)
9 diff
(99.0 %id)
BX384033   TADA2B.a 69 to 1009 1 to 936       936/936
(100 %)
34 diff
(96.4 %id)
DN998415 bone marrow TADA2B.a 95 to 500 1 to 406       406/406
(100 %)
5 diff
(98.8 %id)
BC047794 Peripheral Nervous System, sympathetictrunk TADA2B.a 96 to 1101 1 to 1005   available from MGC, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 1005/1014
(99 %)
3 diff
(99.8 %id)
NM_152293.2   TADA2B.a 104 to 4415 1 to 4312   RefSeq,   4312/4312
(100 %)
0 diff
(100 %id)
AL524576 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized TADA2B.a 216 to 715 1 to 499       499/499
(100 %)
4 diff
(99.2 %id)
AK093974 uterus TADA2B.a 231 to 3104 1 to 2874   tiling clone, available from FLJ,   2874/2874
(100 %)
5 diff
(99.9 %id)
AX748390   TADA2B.a 231 to 3104 1 to 2874       2874/2874
(100 %)
5 diff
(99.9 %id)
DB248658 uterus TADA2B.a 232 to 773 2 to 543   capped   542/542
(100 %)
2 diff
(99.7 %id)
DA338130 hippocampus TADA2B.a 241 to 817 2 to 578   capped   577/577
(100 %)
0 diff
(100 %id)
BI196699 brain, neuroblastoma TADA2B.a 357 to 1125 1 to 772       772/773
(99 %)
17 diff
(97.9 %id)
AL524575 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized TADA2B.a 2184 to 2935 752 to 1   tiling clone,   752/752
(100 %)
7 diff
(99.1 %id)
DB350978 uterus TADA2B.a 2571 to 3104 535 to 1       535/535
(100 %)
2 diff
(99.7 %id)
BC101337 PCR rescued clones TADA2B.b 1 to 1343 17 to 1359 exact tiling clone, Suspected internal deletion 1343/1359
(98 %)
0 diff
(100 %id)
BC101335 PCR rescued clones TADA2B.b 20 to 1343 11 to 1335     Suspected internal deletion 1325/1335
(99 %)
6 diff
(99.6 %id)
BC101336 PCR rescued clones TADA2B.b 20 to 1343 11 to 1335     Suspected internal deletion 1325/1335
(99 %)
6 diff
(99.6 %id)
AK126966 brain TADA2B.c 1 to 4074 2 to 4078 F321S tiling clone, available from FLJ,   4078/4078
(100 %)
9 diff
(99.8 %id)
DA223194 brain TADA2B.c 1 to 557 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
BI909629 leukocyte TADA2B.c 183 to 815 107 to 747       641/751
(85 %)
17 diff
(97.8 %id)
TI_57234864   TADA2B.c 183 to 815 144 to 784       641/788
(81 %)
17 diff
(97.9 %id)
CN285276 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells TADA2B.c 207 to 618 1 to 412       412/412
(100 %)
1 diff
(99.8 %id)
BG171707 hypernephroma, cell line, Kidney TADA2B.c 225 to 939 14 to 733       720/913
(78 %)
42 diff
(95.4 %id)
DA454527 tongue, tumor tissue TADA2B.c 230 to 818 2 to 590   capped   589/589
(100 %)
1 diff
(99.9 %id)
BM916944 blood, natural killer cells, cell line TADA2B.c 324 to 1354 1 to 1041       1041/1121
(92 %)
54 diff
(95.2 %id)
DN989882 brain, whole brain TADA2B.c 395 to 870 29 to 504       476/504
(94 %)
7 diff
(98.7 %id)
DA584455 lung TADA2B.c 428 to 1000 2 to 576   capped   575/575
(100 %)
2 diff
(99.7 %id)
BG116522 duodenal adenocarcinoma, cell line, small intestine TADA2B.c 498 to 1265 1 to 759       759/865
(87 %)
21 diff
(97.6 %id)
DA871620 Prostate TADA2B.c 498 to 950 2 to 454   capped   453/456
(99 %)
2 diff
(99.6 %id)
CR987143 T-Lymphocytes TADA2B.c 542 to 1048 1 to 507       507/507
(100 %)
0 diff
(100 %id)
BC013164 Lymph, lymphoma TADA2B.c 554 to 2640 1 to 2087   tiling clone, available from MGC, AAA   2087/2087
(100 %)
3 diff
(99.9 %id)
BF795676 lymph, lymphoma, cell line TADA2B.c 555 to 1311 1 to 760   available from MGC,   760/760
(100 %)
5 diff
(99.4 %id)
BM917042 blood, natural killer cells, cell line TADA2B.c 639 to 1523 1 to 886       886/1126
(78 %)
21 diff
(98.2 %id)
DN998262 breast cancer, Mammary gland (cancer tissue) TADA2B.c 670 to 1280 9 to 619       611/619
(98 %)
6 diff
(99.1 %id)
BX485220   TADA2B.c 745 to 1374 1 to 630       630/630
(100 %)
4 diff
(99.4 %id)
CR976948 T-Lymphocytes TADA2B.c 767 to 1584 1 to 818   tiling clone,   818/818
(100 %)
3 diff
(99.7 %id)
BX485235   TADA2B.c 768 to 1264 20 to 519       500/519
(96 %)
6 diff
(98.9 %id)
BX486628   TADA2B.c 782 to 1362 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
BM719059 eye, fetal eye TADA2B.c 809 to 1487 1 to 679       679/679
(100 %)
2 diff
(99.8 %id)
BG996703 head_neck TADA2B.c 921 to 1384 474 to 8       467/474
(98 %)
0 diff
(100 %id)
BE867774 adenocarcinoma, colon TADA2B.c 1026 to 1531 1 to 504       504/504
(100 %)
4 diff
(99.3 %id)
Z42579 brain, total brain TADA2B.c 1040 to 1222 1 to 182       182/184
(98 %)
4 diff
(97.9 %id)
DA782629 brain TADA2B.c 1042 to 1611 2 to 574   capped   573/573
(100 %)
11 diff
(98.1 %id)
BM053145 Islets of Langerhans, Pancreas TADA2B.c 1172 to 1749 1 to 578       578/578
(100 %)
1 diff
(99.9 %id)
BM126537 Islets of Langerhans, Pancreas TADA2B.c 1172 to 1740 1 to 569       569/569
(100 %)
1 diff
(99.9 %id)
BQ948650 eye, normal pigmented retinal epithelium TADA2B.c 1252 to 2081 1 to 837       837/845
(99 %)
13 diff
(98.5 %id)
BE621329 epithelioid carcinoma, Pancreas TADA2B.c 1256 to 1974 1 to 717       717/719
(99 %)
9 diff
(98.8 %id)
BX479884   TADA2B.c 1301 to 1832 1 to 532       532/532
(100 %)
3 diff
(99.5 %id)
BM729254 eye, fetal eye TADA2B.c 1322 to 1939 1 to 617       617/621
(99 %)
7 diff
(98.9 %id)
H28854 whole brain TADA2B.c 1355 to 1679 1 to 327       327/327
(100 %)
3 diff
(99.1 %id)
N42858 melanocyte TADA2B.c 1371 to 1850 1 to 481       481/481
(100 %)
5 diff
(99.0 %id)
DA954846 Spleen TADA2B.c 1379 to 1937 2 to 560   capped   559/559
(100 %)
1 diff
(99.9 %id)
BF154669 breast_normal TADA2B.c 1399 to 1763 29 to 392       364/404
(90 %)
4 diff
(99.1 %id)
DA887840   TADA2B.c 1441 to 1982 2 to 543   capped   542/542
(100 %)
4 diff
(99.3 %id)
DB262319 uterus TADA2B.c 1443 to 2013 2 to 572   capped   571/571
(100 %)
2 diff
(99.7 %id)
DR763414 embryonic stem TADA2B.c 1485 to 2236 1 to 752       752/752
(100 %)
1 diff
(99.9 %id)
Z44234 brain, total brain TADA2B.c 1500 to 1858 1 to 358       358/358
(100 %)
4 diff
(98.9 %id)
F07111 brain, total brain TADA2B.c 1500 to 1859 1 to 358       358/358
(100 %)
4 diff
(98.9 %id)
R19859 whole brain TADA2B.c 1508 to 1875 1 to 368       368/376
(97 %)
5 diff
(98.7 %id)
AA400341   TADA2B.c 1517 to 1932 1 to 414       414/414
(100 %)
4 diff
(99.1 %id)
BC078156 Skin, melanotic melanoma. TADA2B.c 1540 to 4074 1 to 2540   tiling clone, available from MGC, AAA   2540/2540
(100 %)
4 diff
(99.9 %id)
BQ422652 melanotic melanoma, skin TADA2B.c 1542 to 2395 1 to 871   available from MGC,   871/894
(97 %)
18 diff
(98.0 %id)
BU528408 epidermoid carcinoma, cell line, lung TADA2B.c 1558 to 2482 1 to 935       935/936
(99 %)
25 diff
(97.4 %id)
CX784521 human embryonic stem cells TADA2B.c 1558 to 2287 1 to 730       730/730
(100 %)
0 diff
(100 %id)
AW327246 blood, T cell leukemia TADA2B.c 1574 to 2027 11 to 464       454/464
(97 %)
6 diff
(98.8 %id)
BC064337 Adrenal cortex, carcinoma TADA2B.c 1574 to 2762 1 to 1189   available from MGC, AAA   1189/1189
(100 %)
0 diff
(100 %id)
BF791664 adrenal cortex carcinoma, cell line, adrenal gland TADA2B.c 1575 to 2305 1 to 728   available from MGC,   728/897
(81 %)
9 diff
(99.0 %id)
W28453 eye, retina TADA2B.c 1618 to 2085 500 to 14       487/568
(85 %)
0 diff
(100 %id)
AW404690 lymph TADA2B.c 1625 to 2091 8 to 474       467/474
(98 %)
6 diff
(98.8 %id)
TI_154141680   TADA2B.c 1625 to 2233 80 to 684       605/703
(86 %)
10 diff
(98.6 %id)
CU447453 epidermis TADA2B.c 1671 to 2274 612 to 8     Submitted on the opposite strand 605/629
(96 %)
0 diff
(100 %id)
BG027296 Bone, osteosarcoma, cell line TADA2B.c 1717 to 2344 1 to 649       649/1147
(56 %)
61 diff
(94.7 %id)
BM151494 leukopheresis TADA2B.c 1760 to 2318 559 to 1       559/559
(100 %)
1 diff
(99.9 %id)
BM761212 lymph node, stomach TADA2B.c 1811 to 2459 1 to 649       649/649
(100 %)
0 diff
(100 %id)
BM844330 lymph node, stomach TADA2B.c 1811 to 2231 1 to 421       421/421
(100 %)
0 diff
(100 %id)
BM844827 lymph node, stomach TADA2B.c 1811 to 2183 1 to 374       374/374
(100 %)
3 diff
(99.2 %id)
TI_57176401   TADA2B.c 1831 to 2604 72 to 845       774/845
(91 %)
6 diff
(99.3 %id)
BI829835 brain, medulla TADA2B.c 1832 to 2604 1 to 773       773/773
(100 %)
2 diff
(99.8 %id)
BE621584 epithelioid carcinoma, Pancreas TADA2B.c 1855 to 2730 888 to 23       866/1031
(83 %)
0 diff
(100 %id)
DA384403 thalamus TADA2B.c 1873 to 2498 2 to 627   capped   626/626
(100 %)
0 diff
(100 %id)
TI_149302297   TADA2B.c 1873 to 2762 961 to 84   AAA   878/967
(90 %)
15 diff
(98.5 %id)
BQ576297 Chondrosarcoma Grade II, Left Pelvis TADA2B.c 1927 to 2640 733 to 19   AAA   715/715
(100 %)
1 diff
(99.9 %id)
TI_59383286   TADA2B.c 1971 to 2841 102 to 988       887/892
(99 %)
33 diff
(96.4 %id)
BM007893 Spleen TADA2B.c 1972 to 2841 1 to 886       886/891
(99 %)
33 diff
(96.3 %id)
W79651 heart TADA2B.c 2039 to 2446 8 to 415   fully sequenced,   408/415
(98 %)
7 diff
(98.4 %id)
CD743174 Alveolar Macrophage, lung TADA2B.c 2040 to 2762 738 to 17   AAA   722/722
(100 %)
1 diff
(99.9 %id)
BM980519 lung, Primary Lung Cystic Fibrosis EpithelialCells TADA2B.c 2044 to 2762 735 to 17   AAA   719/719
(100 %)
0 diff
(100 %id)
CD370689 Alveolar Macrophage, lung TADA2B.c 2046 to 2762 731 to 17   AAA   715/715
(100 %)
2 diff
(99.8 %id)
DA595993   TADA2B.c 2055 to 2863 2 to 806   capped   805/805
(100 %)
13 diff
(98.4 %id)
AW837140 leiomios TADA2B.c 2077 to 2468 405 to 14       392/405
(96 %)
0 diff
(100 %id)
AW837144 leiomios TADA2B.c 2077 to 2468 403 to 12       392/403
(97 %)
0 diff
(100 %id)
BM707675 eye, RPE and Choroid TADA2B.c 2098 to 2389 1 to 292       292/292
(100 %)
0 diff
(100 %id)
BM699992 eye, lens TADA2B.c 2105 to 2710 1 to 606       606/606
(100 %)
0 diff
(100 %id)
BU621750 cell lines, Chondrosarcoma TADA2B.c 2110 to 2767 675 to 19   AAA   657/657
(100 %)
1 diff
(99.9 %id)
BM683036 eye, fetal eye TADA2B.c 2113 to 2767 673 to 19   AAA   655/655
(100 %)
1 diff
(99.9 %id)
DA842070 placenta TADA2B.c 2115 to 2652 2 to 539   capped   538/538
(100 %)
0 diff
(100 %id)
BM682169 eye, fetal eye TADA2B.c 2115 to 2756 660 to 19   AAA   642/642
(100 %)
11 diff
(98.3 %id)
AW467969 myeloid cells, 18 pooled CML cases, BCR/ABLrearrangement positive, includes both chronic phase andmyeloid blast crisis, whole blood TADA2B.c 2167 to 2640 484 to 11   AAA   474/474
(100 %)
2 diff
(99.6 %id)
TI_151746874   TADA2B.c 2204 to 2763 685 to 121       565/1281
(44 %)
0 diff
(100 %id)
AA393158   TADA2B.c 2212 to 2681 1 to 466       466/466
(100 %)
12 diff
(97.5 %id)
AA676638 liver and spleen TADA2B.c 2221 to 2640 420 to 1       420/420
(100 %)
1 diff
(99.8 %id)
AW450084   TADA2B.c 2233 to 2640 425 to 18   AAA   408/408
(100 %)
1 diff
(99.8 %id)
H28724 whole brain TADA2B.c 2251 to 2644 416 to 11   AAA   406/409
(99 %)
16 diff
(96.1 %id)
T17273   TADA2B.c 2253 to 2644 391 to 1       391/393
(99 %)
2 diff
(99.5 %id)
CK904021 Islets of Langerhans, Pancreas TADA2B.c 2258 to 2762 520 to 16   AAA   505/505
(100 %)
0 diff
(100 %id)
AW327602 blood, T cell leukemia TADA2B.c 2262 to 2644 415 to 33   AAA   383/383
(100 %)
1 diff
(99.8 %id)
BU428652 lymph TADA2B.c 2262 to 2533 1 to 272       272/272
(100 %)
19 diff
(93.1 %id)
AI862537 2 pooled tumors (clear cell type), Kidney TADA2B.c 2263 to 2763 506 to 6       501/506
(99 %)
0 diff
(100 %id)
TI_154149476   TADA2B.c 2267 to 2785 76 to 601       526/669
(78 %)
65 diff
(90.3 %id)
BF001672 colon, colon tumor, RER+ TADA2B.c 2274 to 2766 493 to 1       493/493
(100 %)
1 diff
(99.8 %id)
AA599233 bone marrow stroma TADA2B.c 2279 to 2761 483 to 1       483/483
(100 %)
0 diff
(100 %id)
BF221826 Prostate TADA2B.c 2282 to 2762 495 to 15   AAA   481/481
(100 %)
0 diff
(100 %id)
BF512573   TADA2B.c 2284 to 2758 494 to 20   AAA   475/477
(99 %)
0 diff
(100 %id)
N34450 melanocyte TADA2B.c 2291 to 2762 474 to 1       474/474
(100 %)
2 diff
(99.6 %id)
AW264116 brain, three pooled meningiomas TADA2B.c 2315 to 2762 448 to 1       448/448
(100 %)
0 diff
(100 %id)
AI299860 carcinoid, lung TADA2B.c 2316 to 2767 452 to 1       452/452
(100 %)
0 diff
(100 %id)
AI609071 ovary, tumor, 5 pooled (see description) TADA2B.c 2316 to 2763 448 to 1       448/448
(100 %)
1 diff
(99.8 %id)
BG271547 normal head/neck tissue TADA2B.c 2316 to 2763 452 to 5       448/452
(99 %)
0 diff
(100 %id)
AW452070   TADA2B.c 2329 to 2762 449 to 16   AAA   434/434
(100 %)
0 diff
(100 %id)
BM126223 Islets of Langerhans, Pancreas TADA2B.c 2333 to 2762 447 to 16   AAA   432/432
(100 %)
7 diff
(98.4 %id)
AW899149 nervous_normal TADA2B.c 2343 to 2668 328 to 3       326/356
(91 %)
0 diff
(100 %id)
AW899150 nervous_normal TADA2B.c 2343 to 2645 307 to 6       302/418
(72 %)
0 diff
(100 %id)
AA838390 Kidney, kidney tumor TADA2B.c 2346 to 2762 417 to 1       417/417
(100 %)
0 diff
(100 %id)
AA622707 lung, lung tumor TADA2B.c 2347 to 2767 422 to 1       422/422
(100 %)
1 diff
(99.8 %id)
AI299146 carcinoid, lung TADA2B.c 2348 to 2767 420 to 1       420/420
(100 %)
0 diff
(100 %id)
N51114 multiple sclerosis lesions TADA2B.c 2357 to 2762 410 to 1       410/410
(100 %)
5 diff
(98.8 %id)
AI140813 pooled TADA2B.c 2371 to 2767 417 to 21   AAA   397/397
(100 %)
0 diff
(100 %id)
AA400183   TADA2B.c 2376 to 2761 393 to 8       386/393
(98 %)
0 diff
(100 %id)
BU933345 mixed (pool of 40 RNAs) TADA2B.c 2410 to 2762 1 to 353       353/388
(90 %)
4 diff
(99.0 %id)
F33240 pectoral muscle (after mastectomy) TADA2B.c 2412 to 2767 1 to 356   AAA   356/356
(100 %)
1 diff
(99.8 %id)
W74113 heart TADA2B.c 2416 to 2762 348 to 1   fully sequenced,   348/348
(100 %)
2 diff
(99.5 %id)
Z40204 brain, total brain TADA2B.c 2430 to 2762 333 to 1       333/333
(100 %)
0 diff
(100 %id)
DT216991 brain TADA2B.c 2447 to 2766 12 to 331   AAA   320/331
(96 %)
6 diff
(98.2 %id)
R45957 whole brain TADA2B.c 2452 to 2763 332 to 8       325/335
(97 %)
0 diff
(100 %id)
BM052830 Islets of Langerhans, Pancreas TADA2B.c 2480 to 2762 298 to 16   AAA   283/283
(100 %)
1 diff
(99.7 %id)
F03384 brain, total brain TADA2B.c 2491 to 2762 272 to 1       272/272
(100 %)
0 diff
(100 %id)
F02091 brain, total brain TADA2B.c 2611 to 2767 157 to 1       157/157
(100 %)
0 diff
(100 %id)
CF141390 CNCAP(3)T-225 cell line, Prostate TADA2B.c 2688 to 3197 8 to 517       510/517
(98 %)
1 diff
(99.9 %id)
TI_154172101   TADA2B.c 2688 to 3248 90 to 651       562/1117
(50 %)
9 diff
(99.2 %id)
CF147026 CNCAP(3)T-225 cell line, Prostate TADA2B.c 2794 to 3542 7 to 751       745/751
(99 %)
6 diff
(99.3 %id)
TI_154179582   TADA2B.c 2794 to 3601 76 to 875       800/811
(98 %)
13 diff
(98.4 %id)
BQ422358 large cell carcinoma, lung TADA2B.c 2878 to 3677 16 to 813       798/813
(98 %)
0 diff
(100 %id)
BF032607 adenocarcinoma, ovary TADA2B.c 2892 to 3688 1 to 799       799/857
(93 %)
28 diff
(96.8 %id)
BX090165   TADA2B.c 2938 to 3386 12 to 460       449/460
(97 %)
11 diff
(97.7 %id)
AA497090   TADA2B.c 2939 to 3196 1 to 258       258/258
(100 %)
0 diff
(100 %id)
BM909488 lymph, lymphoma, cell line TADA2B.c 2964 to 3831 1 to 869       869/1028
(84 %)
30 diff
(97.1 %id)
BU553434 ovary, teratocarcinoma, cell line TADA2B.c 3102 to 3910 1 to 816   AAA   816/818
(99 %)
11 diff
(98.7 %id)
AI351879 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus TADA2B.c 3127 to 3464 346 to 9       338/346
(97 %)
0 diff
(100 %id)
BM688929 eye, eye anterior segment TADA2B.c 3194 to 3642 9 to 457       449/457
(98 %)
6 diff
(98.7 %id)
AI350914 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus TADA2B.c 3214 to 3464 261 to 9       253/261
(96 %)
0 diff
(100 %id)
CB147801 Liver TADA2B.c 3305 to 3639 1 to 335       335/335
(100 %)
11 diff
(96.8 %id)
BG765971 melanotic melanoma, high MDR (cell line), skin TADA2B.c 3319 to 3902 1 to 588       588/822
(71 %)
38 diff
(95.4 %id)
BQ182490 Knee, Osteoarthritic Cartilage TADA2B.c 3321 to 4074 771 to 16   AAA   756/756
(100 %)
9 diff
(98.9 %id)
CA428724 Bone, Subchondral Bone TADA2B.c 3321 to 4074 775 to 19   tiling clone, AAA   757/757
(100 %)
3 diff
(99.7 %id)
BU617429 Bone, Subchondral Bone TADA2B.c 3323 to 4074 771 to 19   AAA   753/753
(100 %)
5 diff
(99.4 %id)
CB115054 Liver TADA2B.c 3389 to 4041 1 to 656       656/656
(100 %)
3 diff
(99.6 %id)
BQ946341 leiomyosarcoma, uterus TADA2B.c 3437 to 4073 1 to 643   AAA   643/645
(99 %)
10 diff
(98.5 %id)
DB319789   TADA2B.c 3441 to 3911 474 to 1       474/474
(100 %)
6 diff
(98.8 %id)
BM511372 insulinoma, Pancreas TADA2B.c 3472 to 3969 8 to 509       502/509
(98 %)
6 diff
(98.9 %id)
CK820440 insulinoma, Pancreas TADA2B.c 3490 to 4062 576 to 1       576/576
(100 %)
5 diff
(99.2 %id)
DB305078 brain TADA2B.c 3560 to 4074 517 to 1       517/517
(100 %)
5 diff
(99.1 %id)
AI859834 serous papillary carcinoma, high grade, 2pooled tumors, uterus TADA2B.c 3599 to 4078 487 to 5       483/487
(99 %)
0 diff
(100 %id)
BQ441400 testis TADA2B.c 3638 to 4073 1 to 439       439/474
(92 %)
5 diff
(99.0 %id)
AI979005 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors TADA2B.c 3642 to 4060 423 to 1       423/423
(100 %)
7 diff
(98.4 %id)
AA663966 lung TADA2B.c 3650 to 4074 428 to 1       428/428
(100 %)
3 diff
(99.3 %id)
AI151407 placenta TADA2B.c 3665 to 4075 414 to 1       414/414
(100 %)
3 diff
(99.3 %id)
AL712689 human skeletal muscle TADA2B.c 3839 to 4074 1 to 239   AAA   239/239
(100 %)
3 diff
(98.8 %id)
AA855093 parathyroid gland, parathyroid tumor TADA2B.c 3866 to 4078 219 to 4   tiling clone,   216/219
(98 %)
0 diff
(100 %id)
AI471901 lymph node, lymphoma, follicular mixed small and largecell TADA2B.c 3930 to 4076 146 to 1       146/146
(100 %)
1 diff
(99.4 %id)
DB088177 testis TADA2B.d-u 1 to 547 2 to 552   tiling clone, capped   551/551
(100 %)
3 diff
(99.5 %id)
AK096655 brain TADA2B.d-u 423 to 4240 1 to 3818 exact tiling clone, available from FLJ,   3818/3818
(100 %)
5 diff
(99.9 %id)
DA782091 brain TADA2B.d-u 424 to 989 2 to 569   capped   568/568
(100 %)
2 diff
(99.7 %id)
BX641147 human small intestine TADA2B.d-u 1492 to 4235 1 to 2744 E159K available from DKFZ, AAA   2744/2745
(99 %)
7 diff
(99.8 %id)
BX648428 human salivary gland TADA2B.d-u 1667 to 5548 1 to 3886 I83T tiling clone, available from DKFZ, AAA   3886/3887
(99 %)
14 diff
(99.7 %id)
DB326290 brain TADA2B.d-u 3706 to 4240 536 to 1       536/536
(100 %)
1 diff
(99.9 %id)
BE244430 leukopheresis TADA2B.e-u 1 to 467 1 to 469 exact tiling clone,   469/469
(100 %)
3 diff
(99.4 %id)
BM152557 leukopheresis TADA2B.e-u 1 to 554 1 to 554 exact tiling clone,   554/563
(98 %)
5 diff
(99.2 %id)
DB061100 testis TADA2B.f 1 to 543 2 to 544 exact tiling clone, capped   543/543
(100 %)
0 diff
(100 %id)
AK026299 human small intestine Gene TADA2B, variant not shown       available from FLJ, AAA Suspected internal deletion, this clone was ignored    
BC101334 PCR rescued clones Gene TADA2B, variant not shown         Suspected internal deletion, this clone was ignored    
AA905662 pooled Gene TADA2B, variant not shown         This clone was ignored    
CR992143 T-Lymphocytes Gene TADA2B, variant not shown         Suspected internal deletion, this clone was ignored    
CR986778 T-Lymphocytes Gene TADA2B, variant not shown         Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d-u, .e-u, .f Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI